According to the results of our prognostic analysis, high expression of COL5A2, COL6A3, COL11A1, COL12A1, FBN1, POSTN, THBS2, SPARC, or VCAN was associated with poor prognosis for patients with pancreatic cancer. This evidence concerns the gene COL12A1 and familial pancreatic carcinoma.